A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age

NCT02580201 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: Oral Polio Vaccine

Sponsor

Fidec Corporation

Collaborators

[object Object]